Searched for
COVID 19 MANUFACTURING
India's private investment gains overtakes government share post-COVID: ReportPrivate companies have emerged as the main drivers of investment in India after the pandemic, accounting for 71.3% of project announcements...- Britain's economic woes fuel discontent with Brexit a decade after historic vote to leave EUA decade after Britain's vote to leave the European Union, business leaders like Simon Boyd and Mike Hawes express frustration. Promises of...
- Reliance AGM 2026 Key Highlights: From Jio IPO, AI ventures to retail bets, check key announcements by Mukesh AmbaniRIL AGM 2026 Key Highlights: Reliance Industries Chairman Mukesh Ambani unveiled major plans at the company's annual general meeting. Key a...
- Avience Biomedicals IPO: Check GMP, price band and other detailsThe grey market premium (GMP) for the issue stood at 36% ahead of the opening, implying an unofficial market price of around Rs 283 against...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 27%As the market seems to be in comeback mode, it helps to be aware that the best (and probably biggest) wealth creator of the last couple of ...
- He once scored 51 marks in Maths, now owns a space company worth $1.1 billion. Meet 35-year-old rocket man who gave up ISRO jobPawan Kumar Chandana, once a struggling student, now leads Skyroot Aerospace. This company achieved India's first private rocket launch. Ch...
- Workplace as strategy: Steelcase driving performance beyond designThe Indian workplace is transforming, with companies like Steelcase shifting from furniture suppliers to partners in workplace evolution. R...
- ETMarkets Smart Talk | Defence and electrification are multi-year structural themes for India: Prateek AgrawalGeopolitical shifts and the drive for self-reliance are creating long-term investment opportunities in India's defence and electrification ...
- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...
- Why the G7 is worried about global economic imbalancesIn a pivotal discussion at the G7 summit, France is highlighting urgent concerns about the global economic landscape. China's robust export...
- 12 years, economic growth and a 'new dawn': PM Modi hails NDA's journey, sets agenda for India's next phasePrime Minister Modi highlighted the NDA's 12-year governance record, emphasizing political stability and development achievements. He contr...
- 12 years of PM Modi: Bold reforms, decisive decisions and political turning pointsAfter 12 years at the helm, Prime Minister Narendra Modi reflects on a transformative journey filled with key reforms that have altered Ind...
- 144 years later, Gaudí's masterpiece Sagrada Família finally reaches its full height: Why has the world’s most famous church taken so long to build and how much did it cost?Barcelona's Sagrada Familia has reached a historic milestone. After 144 years, the final major tower, the Tower of Jesus Christ, is complet...
- 100 days of Iran war: India must brace for broad-based economic shockIn a volatile turn of events, escalating strikes between Iran and Israel are sending shockwaves that may reach India’s economy. As the spec...
- Textile stocks to rally? Emkay sees sector at inflection point to regain lost glory, initiates 'Buy' call on 3 stocksIndia’s textile sector is nearing an inflection point and could regain lost global market share, according to Emkay Global. The brokerage i...
- More economic safeguards on the cards as West Asia conflict persists: ReportIndia is preparing new measures to protect its economy from the West Asia conflict. The government will introduce these steps gradually as ...
- Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
- Serum Institute of India to manufacture Oxford Ebola vaccine backed by $8.6 million CEPI fundingSerum Institute of India will produce clinical trial doses of a new Ebola vaccine from Oxford University. This initiative is backed by fres...
- Moderna and other groups get $60 million to develop Ebola vaccineCEPI is investing around $60 million to speed up the creation of vaccines against the deadly Ebola Bundibugyo virus. This funding will supp...
- Global Market: Eurozone inflation stays above ECB target as fuel costs begin to filter throughInflation across the euro zone’s four largest economies stayed above the European Central Bank’s 2% target for a third consecutive month in...
Load More
